Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDO2 | P48775 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | PPARG | P37231 | 1/20 | 0.56 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.56 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.56 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.50 |
| ▸ | LMNA | P02545 | 5/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL367037 | 0.98 | TDO2 (0.59) | TDO2ALDH1A1KDM4EPPARGNCOA2 | |
| SCHEMBL11772421 | 0.89 | MEN1 (0.50) | TDO2ALDH1A1KDM4EPPARGNCOA2 | |
| SCHEMBL11769189 | 0.82 | HSD17B1 (0.47) | TDO2ALDH1A1KDM4EPPARGNCOA2 | |
| SCHEMBL8918835 | 0.82 | PTGS2 (0.76) | ALDH1A1LMNAPTGS2NPSR1MAPT | |
| SCHEMBL8918833 | 0.82 | PTGS2 (0.76) | ALDH1A1LMNAPTGS2NPSR1MAPT | |
| SCHEMBL11769207 | 0.79 | L3MBTL1 (0.49) | TDO2ALDH1A1KDM4EPPARGNCOA2 | |
| SCHEMBL2064328 | 0.79 | ALDH1A1 (0.49) | TDO2ALDH1A1KDM4EPPARGNCOA2 | |
| SCHEMBL29873679 | 0.79 | L3MBTL1 (0.49) | TDO2ALDH1A1KDM4EPPARGNCOA2 | |
| SCHEMBL2064327 | 0.79 | ALDH1A1 (0.56) | TDO2ALDH1A1KDM4EPPARGNCOA2 | |
| SCHEMBL10166468 | 0.76 | TDO2 (0.59) | TDO2ALDH1A1KDM4EPPARGNCOA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 267 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060222997-A1 | Adhesion improver for photosensitive resin composition and photosensitive resin composition containing same | KOBAYASHI SATOSHI | 2006-10-05 | — | — | US | claimed |
| US-6835468-B2 | Fluorene based polymers and light emitting diodes fabricated with the same as light emitting material | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KIST) (KR) | 2004-12-28 | — | — | US | claimed |
| US-20020051895-A1 | Fluorene based polymers and light emitting diodes fabricated with the same as light emitting material | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KIST) | 2002-05-02 | — | — | US | claimed |
| EP-1146905-A1 | COX-2 INHIBITORS IN COMBINATION WITH NMDA-BLOCKERS FOR TREATING PAIN | Algos Pharmaceutical Corporation (US) | 2001-10-24 | — | — | EP | claimed |
| WO-2000029022-A1 | COX-2 INHIBITORS IN COMBINATION WITH CENTRALLY ACTING ANALGESICS | ALGOS PHARMACEUTICAL CORPORATION (US) | 2000-05-25 | — | — | WO | claimed |
| WO-2000029023-A1 | COX-2 INHIBITORS IN COMBINATION WITH NMDA-BLOCKERS FOR TREATING PAIN | ALGOS PHARMACEUTICAL CORPORATION (US) | 2000-05-25 | — | — | WO | claimed |
| US-5876864-A | Fluorene-based alternating polymers containing acetylene group and electroluminescence element using the same | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY | 1999-03-02 | — | — | US | claimed |
| US-5807974-A | POLYARYLENEVINYLENE RESIN | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 1998-09-15 | — | — | US | claimed |
| US-RE34726-E | Ferroelectric liquid crystal compositions containing chiral haloalkoxy tail units | DISPLAYTECH, INC. (US) | 1994-09-13 | — | — | US | claimed |
| US-5167855-A | Electrooptics and display devices | UNIVERSITY RESEARCH CORPORATION (US) | 1992-12-01 | — | — | US | claimed |
| US-5130048-A | Enantiomorphs for optical apparatus | DISPLAYTECH, INC. (US) | 1992-07-14 | — | — | US | claimed |
| US-11905525-B2 | Reduction of elimination of immune responses to non-intravenous, e.g., subcutaneously administered therapeutic proteins | MODERNATX, INC. (US) | 2024-02-20 | — | — | US | disclosed |
| US-20230403928-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-12-14 | — | — | US | disclosed |
| US-11435363-B2 | Relevance of achieved levels of markers of systemic inflammation following treatment | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 2022-09-06 | — | — | US | disclosed |
| US-20220047518-A1 | PEG LIPIDS AND USES THEREOF | Moderna TX, Inc. (US) | 2022-02-17 | — | — | US | disclosed |
| WO-2000029022-A1 | COX-2 INHIBITORS IN COMBINATION WITH CENTRALLY ACTING ANALGESICS | ALGOS PHARMACEUTICAL CORPORATION (US) | 2000-05-25 | — | — | WO | disclosed |
| US-5876864-A | Fluorene-based alternating polymers containing acetylene group and electroluminescence element using the same | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY | 1999-03-02 | — | — | US | disclosed |
| US-5807974-A | POLYARYLENEVINYLENE RESIN | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 1998-09-15 | — | — | US | disclosed |
| US-5759444-A | FLAT LIGHT SOURCE OR DISPLAY; BRIGHTNESS, STABILITY | TOYO INK MANUFACTURING CO., LTD. (JP) | 1998-06-02 | — | — | US | disclosed |
| US-5677318-A | Diphenyl-1,2-3-thiadiazoles as anti-inflammatory agents | MERCK FROSST CANADA, INC. (CA) | 1997-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220047518-A1 | PEG LIPIDS AND USES THEREOF | LIPA, LIPG, LNPEP | TDO2 4616/4885ALDH1A1 1384/4885KDM4E 2303/4885 |
| US-11905525-B2 | Reduction of elimination of immune responses to non-intravenous, e.g., subcutaneously administered therapeutic proteins | CD47, FCGR3B, MSR1 | TDO2 4841/4885ALDH1A1 3761/4885KDM4E 3474/4885 |
| US-20230403928-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CYP1A1, CYP2E1 | TDO2 552/4885ALDH1A1 13/4885KDM4E 2491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.